Bank OZK Sells 1,115 Shares of CVS Health Co. (NYSE:CVS)

Bank OZK lowered its position in CVS Health Co. (NYSE:CVS) by 16.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 5,869 shares of the pharmacy operator’s stock after selling 1,115 shares during the period. Bank OZK’s holdings in CVS Health were worth $463,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the company. Atticus Wealth Management LLC increased its holdings in CVS Health by 149.0% during the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 219 shares in the last quarter. Cornerstone Planning Group LLC increased its holdings in CVS Health by 111.5% during the 3rd quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 243 shares in the last quarter. ZRC Wealth Management LLC boosted its stake in shares of CVS Health by 400.0% during the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock worth $39,000 after buying an additional 400 shares during the last quarter. Coston McIsaac & Partners boosted its stake in shares of CVS Health by 42.6% during the 4th quarter. Coston McIsaac & Partners now owns 539 shares of the pharmacy operator’s stock worth $42,000 after buying an additional 161 shares during the last quarter. Finally, Tennessee Valley Asset Management Partners acquired a new position in shares of CVS Health during the 4th quarter worth about $50,000. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on CVS. Leerink Partnrs restated an “outperform” rating on shares of CVS Health in a research note on Monday, February 26th. Barclays assumed coverage on shares of CVS Health in a research note on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price objective for the company. Wells Fargo & Company cut their target price on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating for the company in a research note on Monday, April 8th. StockNews.com downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $87.00 target price on shares of CVS Health in a research note on Wednesday, April 10th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $89.44.

CVS Health Stock Performance

CVS stock traded down $0.15 during mid-day trading on Friday, hitting $67.18. 6,396,438 shares of the company were exchanged, compared to its average volume of 8,376,818. The business has a 50 day simple moving average of $74.42 and a 200-day simple moving average of $73.64. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $84.68 billion, a PE ratio of 10.40, a price-to-earnings-growth ratio of 0.89 and a beta of 0.52. CVS Health Co. has a 1-year low of $64.41 and a 1-year high of $83.25.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping the consensus estimate of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The company had revenue of $93.81 billion for the quarter, compared to analysts’ expectations of $90.58 billion. During the same period last year, the firm earned $1.99 earnings per share. The business’s revenue for the quarter was up 11.9% on a year-over-year basis. On average, equities analysts forecast that CVS Health Co. will post 8.31 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be issued a dividend of $0.665 per share. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.66 annualized dividend and a dividend yield of 3.96%. CVS Health’s dividend payout ratio is presently 41.18%.

Insider Transactions at CVS Health

In other news, EVP Prem S. Shah sold 29,473 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.24% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.